Advance your GLP-1 research with optimized assays
The growing interest in GLP-1 receptor agonists underscores their potential, not only in helping manage diabetes and obesity, but also in offering possible benefits for kidney and heart health.
We offer an extensive portfolio of immunoassays optimized for ease of use and available for multiple species—from rodent to bovine to human. Many assays are available in both colorimetric and chemiluminescent formats.
View our featured products below.
GLP-1 ELISAs
Human Insulin ELISAs
Mouse Insulin ELISAs
Human C-peptide ELISAs
Rodent C-peptide ELISAs
Human Proinsulin ELISAs
Human Glucagon Immunoassays
ALPCO GLP-1 Resources to Advance your discoveries
Understanding the Role of Energy Homeostasis in Diabetes
The prevalence of diabetes and obesity has been on the rise for several decades and research has demonstrated that other parts of the body, including the cardiovascular system and kidneys, can be affected by diabetes.
Incretins GIP and GLP-1 in Diabetes and Obesity
The CDC reports that severe obesity leads to life-altering and often life-threatening conditions like heart disease, stroke, type 2 diabetes, and certain cancers.
Celebrating Diabetes Research
In honor of scientists and researchers in the field of diabetes, we've compiled a partial list of their 2023 published work. These publications aren't just studies; they're milestones on the path to a healthier future, made possible by their dedication.
Follow ALPCO on Social Media
Stay up to date with new products, articles, and events.